M. C. Pedroso de Lima

Publications87
h-index35
Citations3,891
Highly Influential Citations110
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • N. Düzgüneş
  • 237 Publications, 12,291 Citations
  • S. Simões
  • 74 Publications, 3,062 Citations
  • C. Croce
  • 1,604 Publications, 180,373 Citations
  • S. Nir
  • 85 Publications, 5,551 Citations
  • Publications
  • Influence
Age differences in personality across the adult life span: parallels in five cultures.
Both cross-sectional and longitudinal studies in the United States have shown consistent changes between college age and middle adulthood. There appear to be declines in 3 of the 5 major factors of… Expand
  • 398
  • 29
Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph Disease
Recent studies have demonstrated that RNAi is a promising approach for treating autosomal dominant disorders. However, discrimination between wild-type and mutant transcripts is essential, to… Expand
  • 131
  • 9
  • PDF
Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?
Machado-Joseph disease or spinocerebellar ataxia type 3 (MJD/SCA3) is a fatal, autosomal dominant disorder caused by a cytosine-adenine-guanine expansion in the coding region of the MJD1 gene. RNA… Expand
  • 92
  • 6
  • PDF
Intranasal Administration of Novel Chitosan Nanoparticle/DNA Complexes Induces Antibody Response to Hepatitis B Surface Antigen in Mice.
The generation of strong pathogen-specific immune responses at mucosal surfaces where hepatitis B virus (HBV) transmission can occur is still a major challenge. Therefore, new vaccines are urgently… Expand
  • 38
  • 6
Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications.
Great expectations from the application of gene therapy approaches to human disease have been impaired by the unsatisfactory clinical progress observed. Among others, the use of an efficient carrier… Expand
  • 315
  • 5
Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
RNA interference (RNAi) is a specific gene-silencing mechanism that can be mediated by the delivery of chemical synthesized small-interfering RNA (siRNA). RNAi might constitute a novel therapeutic… Expand
  • 154
  • 5
MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma.
Highly malignant glioblastoma (GBM) is characterized by high genetic heterogeneity and infiltrative brain invasion patterns, and aberrant miRNA expression has been associated with hallmark malignant… Expand
  • 65
  • 5
  • PDF
Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment.
The present work aimed at the development and application of transferrin receptor (TrfR)-targeted sterically stabilized liposomes encapsulating anti-BCR-ABL siRNA or asODN. Transferrin was coupled to… Expand
  • 86
  • 4
On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide.
Cell-penetrating peptides have been shown to translocate across eukaryotic cell membranes through a temperature-insensitive and energy-independent mechanism that does not involve membrane receptors… Expand
  • 84
  • 3
  • PDF
Cationic liposomes for gene delivery: from biophysics to biological applications.
The use of an efficient carrier for nucleic acid-based medicines is considered to be a determinant factor for the successful application of gene therapy. The drawbacks associated with the use of… Expand
  • 139
  • 3